Zantak acid may include carcinogens: FDA



Friday, September 13, 2019 (HealthDay News) - Cancer drugs, including acidity and ulcers and brand-name drugs, can be found in zantak symptoms, the source of the investigation, an ongoing contamination, the US Food and Drug Administration management said.

The initial test of the product is characterized by small amounts of colorless nitrosamine N-nitrosodimethylamine (NDMA), but just because you, it does not mean that patients should stop using them.

NDMA bought many brands in the last year, including blood pressure and heart disease.

Demonstration of ranitidine makes patients want to stop using it should their health care competitor rival it. Those taking over the counter (OTC) are, ranitidine may be replaced by other OTC drugs.

Many drugs are approved for the same or similar use, the FDA said.

Comments